A phase 1 trial has reported positive safety findings of SON-1010 among patients with advanced leiomyosarcoma (LMS) or ...

SON-1010 is being studied as a combination therapy with trabectedin (Yondelis®), the first FDA-approved treatment for two types of advanced soft tissue sarcoma after failure of standard chemotherapy, ...

Friends of a Hants County teen battling a rare form of bone cancer have launched an online fundraiser to benefit him and his ...

Announced demonstrated ability to deliver transient gene therapy (payload) to tumors using systemic antitumor virotherapy platformFiled IND in ...

And the big thing is that there's really more than a hundred different kinds of sarcomas, which collectively altogether make up only 1% of adult cancers. And so we talk about these as being bone and ...

Furthermore, the global market opportunity for trabectedin is $2.1B and sarcoma still represents an unmet medical need, which we believe opens up another potential opportunity for partnering.” For ...

Support poured in for a suburban police officer, who is a father of five boys, as he battled cancer and had to have his foot amputated.

Cure Cancer’s campaign is encouraging Australians to turn their next BBQ into a BarbeCURE, an opportunity to raise money for cancer research ...